250 related articles for article (PubMed ID: 8816426)
41. Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity.
Morgenthaler NG; Kim MR; Tremble J; Huang GC; Richter W; Gupta M; Scherbaum WA; McGregor AM; Banga JP
J Clin Endocrinol Metab; 1996 Sep; 81(9):3155-61. PubMed ID: 8784060
[TBL] [Abstract][Full Text] [Related]
42. Insight into Graves' hyperthyroidism from animal models.
McLachlan SM; Nagayama Y; Rapoport B
Endocr Rev; 2005 Oct; 26(6):800-32. PubMed ID: 15827111
[TBL] [Abstract][Full Text] [Related]
43. Kappa/lambda immunoglobulin distribution in Graves' thyroid-stimulating antibodies. Simultaneous analysis of C lambda gene polymorphisms.
Williams RC; Marshall NJ; Kilpatrick K; Montano J; Brickell PM; Goodall M; Ealey PA; Shine B; Weetman AP; Craig RK
J Clin Invest; 1988 Oct; 82(4):1306-12. PubMed ID: 2902107
[TBL] [Abstract][Full Text] [Related]
44. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
45. Identification of the peptides that inhibit the function of human monoclonal thyroid-stimulating antibodies from phage-displayed peptide library.
Byun CH; Park JY; Akamizu T; Chae CB
J Clin Endocrinol Metab; 2001 Jul; 86(7):3311-8. PubMed ID: 11443206
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of an scFv antibody fragment that binds to immunoglobulin G of Graves' disease patients and inhibits autoantibody-mediated thyroid-stimulating activity.
Zhao Y; Wang SL; Li Q; Ye J; Chen KM; Tian EJ; Chen ZP
Hybridoma (Larchmt); 2008 Dec; 27(6):445-51. PubMed ID: 19108617
[TBL] [Abstract][Full Text] [Related]
47. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.
Knight J; Laing P; Knight A; Adams D; Ling N
J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105
[TBL] [Abstract][Full Text] [Related]
48. Ig repertoire of human polyspecific antibodies and B cell ontogeny.
Guigou V; Guilbert B; Moinier D; Tonnelle C; Boubli L; Avrameas S; Fougereau M; Fumoux F
J Immunol; 1991 Feb; 146(4):1368-74. PubMed ID: 1846900
[TBL] [Abstract][Full Text] [Related]
49. Use of Epstein-Barr virus-based vectors for expression of thyroid auto-antigens in human B-lymphoblastoid cell lines.
McIntosh RS; Mulcahy AF; Hales JM; Diamond AG
J Autoimmun; 1993 Jun; 6(3):353-65. PubMed ID: 8397716
[TBL] [Abstract][Full Text] [Related]
50. Correlation of microsomal antibodies with the intensity of the intrathyroidal autoimmune process in Graves' disease.
Paschke R; Vogg M; Swillens S; Usadel KH
J Clin Endocrinol Metab; 1993 Oct; 77(4):939-43. PubMed ID: 8408468
[TBL] [Abstract][Full Text] [Related]
51. Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment.
Chapman CJ; Spellerberg MB; Smith GA; Carter SJ; Hamblin TJ; Stevenson FK
J Immunol; 1993 Jul; 151(2):1051-61. PubMed ID: 8393034
[TBL] [Abstract][Full Text] [Related]
52. Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients.
Tahara K; Ban T; Minegishi T; Kohn LD
Biochem Biophys Res Commun; 1991 Aug; 179(1):70-7. PubMed ID: 1883391
[TBL] [Abstract][Full Text] [Related]
53. Amplification by polymerase chain reaction of immunoglobulin heavy and light chain genes from orbital tissue of patients with Graves' ophthalmopathy.
McLachlan SM; Prummel MF; Dallow RL; Wiersinga WM; Rapoport B
Autoimmunity; 1993; 16(2):149-52. PubMed ID: 8180319
[No Abstract] [Full Text] [Related]
54. Immunoglobulin heavy chain variable region genes contribute to the induction of thyroid-stimulating antibodies in recombinant inbred mice.
Rapoport B; Williams RW; Chen CR; McLachlan SM
Genes Immun; 2010 Apr; 11(3):254-63. PubMed ID: 20407472
[TBL] [Abstract][Full Text] [Related]
55. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
Zakarija M
Horm Res; 1980; 13(1):1-15. PubMed ID: 6777285
[TBL] [Abstract][Full Text] [Related]
56. Thyroid-stimulating antibodies in patients with autoimmune disorders.
Strakosch CR; Joyner D; Wall JR
J Clin Endocrinol Metab; 1978 Aug; 47(2):361-5. PubMed ID: 263731
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr virus reactivation in peripheral B lymphocytes induces IgM-type thyrotropin receptor autoantibody production in patients with Graves' disease.
Nagata K; Hayashi K; Kumata K; Satoh Y; Osaki M; Nakayama Y; Kuwamoto S; Ichihara Y; Okura T; Matsuzawa K; Miake J; Fukata S; Imamura T
Endocr J; 2023 Jun; 70(6):619-627. PubMed ID: 36908137
[TBL] [Abstract][Full Text] [Related]
58. A method for identification of the peptides that bind to a clone of thyroid-stimulating antibodies in the serum of Graves' disease patients.
Na CH; Lee MH; Cho BY; Chae CB
J Clin Endocrinol Metab; 2003 Apr; 88(4):1570-6. PubMed ID: 12679441
[TBL] [Abstract][Full Text] [Related]
59. A human anti-insulin IgG autoantibody apparently arises through clonal selection from an insulin-specific "germ-line" natural antibody template. Analysis by V gene segment reassortment and site-directed mutagenesis.
Ichiyoshi Y; Zhou M; Casali P
J Immunol; 1995 Jan; 154(1):226-38. PubMed ID: 7995943
[TBL] [Abstract][Full Text] [Related]
60. High affinity, thyroid-specific human autoantibodies displayed on the surface of filamentous phage use V genes similar to other autoantibodies.
Portolano S; McLachlan SM; Rapoport B
J Immunol; 1993 Sep; 151(5):2839-51. PubMed ID: 8360495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
